Article Details

Seaport Therapeutics: $225 Million (Series B) Raised To Advance Novel Neuropsychiatric Medicines

Retrieved on: 2024-10-22 15:00:18

Tags for this article:

Click the tags to see associated articles and topics

Seaport Therapeutics: $225 Million (Series B) Raised To Advance Novel Neuropsychiatric Medicines. View article details on hiswai:

Excerpt

... new investors. Founding investors ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, and co-founder PureTech Health also joined.

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up